These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38211946)

  • 1. Application of hypothetical strategies in acute pain.
    Zhong J; Petullo D
    Pharm Stat; 2024; 23(3):399-407. PubMed ID: 38211946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A narrative review of estimands in drug development and regulatory evaluation: old wine in new barrels?
    Mitroiu M; Oude Rengerink K; Teerenstra S; Pétavy F; Roes KCB
    Trials; 2020 Jul; 21(1):671. PubMed ID: 32703247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods.
    Olarte Parra C; Daniel RM; Bartlett JW
    Stat Biopharm Res; 2023; 15(2):421-432. PubMed ID: 37260584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study.
    Rehal S; Cro S; Phillips PP; Fielding K; Carpenter JR
    Clin Trials; 2023 Oct; 20(5):497-506. PubMed ID: 37277978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating estimands into clinical trial statistical analysis plans.
    Kang M; Kendall MA; Ribaudo H; Tierney C; Zheng L; Smeaton L; Lindsey JC
    Clin Trials; 2022 Jun; 19(3):285-291. PubMed ID: 35257600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining estimands using a mix of strategies to handle intercurrent events in clinical trials.
    Qu Y; Shurzinske L; Sethuraman S
    Pharm Stat; 2021 Mar; 20(2):314-323. PubMed ID: 33098267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining Clinical Trial Estimands: A Practical Guide for Study Teams with Examples Based on a Psychiatric Disorder.
    Polverejan E; O'Kelly M; Hefting N; Norton JD; Lim P; Walton MK
    Ther Innov Regul Sci; 2023 Sep; 57(5):911-939. PubMed ID: 37244885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice.
    Ratitch B; Bell J; Mallinckrodt C; Bartlett JW; Goel N; Molenberghs G; O'Kelly M; Singh P; Lipkovich I
    Ther Innov Regul Sci; 2020 Mar; 54(2):324-341. PubMed ID: 32072573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice.
    Mallinckrodt CH; Bell J; Liu G; Ratitch B; O'Kelly M; Lipkovich I; Singh P; Xu L; Molenberghs G
    Ther Innov Regul Sci; 2020 Mar; 54(2):353-364. PubMed ID: 32072593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of ICH E9 (R1): A Few Points Learned During the COVID-19 Pandemic.
    Qu Y; Lipkovich I
    Ther Innov Regul Sci; 2021 Sep; 55(5):984-988. PubMed ID: 33983621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the Estimand Framework to Anesthesia Trials.
    De Silva AP; Leslie K; Braat S; Grobler AC
    Anesthesiology; 2024 Jul; 141(1):13-23. PubMed ID: 38743905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-world intervention graphs for defining, identifying, and communicating estimands in clinical trials.
    Ocampo A; Bather JR
    Stat Med; 2023 Sep; 42(21):3892-3902. PubMed ID: 37340887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands framework.
    Mitroiu M; Teerenstra S; Oude Rengerink K; Pétavy F; Roes KCB
    Pharm Stat; 2022 Sep; 21(5):1037-1057. PubMed ID: 35678545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for composite estimands in confirmatory clinical trials: Examples from trials in nasal polyps and steroid reduction.
    Keene ON
    Pharm Stat; 2019 Jan; 18(1):78-84. PubMed ID: 30370691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marking 2-Years of New Thinking in Clinical Trials: The Estimand Journey.
    Fletcher C; Hefting N; Wright M; Bell J; Anzures-Cabrera J; Wright D; Lynggaard H; Schueler A
    Ther Innov Regul Sci; 2022 Jul; 56(4):637-650. PubMed ID: 35462609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining estimands for efficacy assessment in single arm phase 1b or phase 2 clinical trials in oncology early development.
    Englert S; Mercier F; Pilling EA; Homer V; Habermehl C; Zimmermann S; Kan-Dobrosky N
    Pharm Stat; 2023; 22(5):921-937. PubMed ID: 37403434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A note on the draft International Council for Harmonisation guidance on estimands and sensitivity analysis.
    Mehrotra DV
    Clin Trials; 2019 Aug; 16(4):339-344. PubMed ID: 30977390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?: Insights and Perspectives From the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum.
    Morga A; Latimer NR; Scott M; Hawkins N; Schlichting M; Wang J
    Value Health; 2023 Feb; 26(2):234-242. PubMed ID: 36150999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimands in practice: Bridging the gap between study objectives and statistical analysis.
    Phillips A; Clark T
    Pharm Stat; 2021 Jan; 20(1):68-76. PubMed ID: 32893473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining Efficacy Estimands in Clinical Trials: Examples Illustrating ICH E9(R1) Guidelines.
    Ratitch B; Goel N; Mallinckrodt C; Bell J; Bartlett JW; Molenberghs G; Singh P; Lipkovich I; O'Kelly M
    Ther Innov Regul Sci; 2020 Mar; 54(2):370-384. PubMed ID: 32072586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.